About
About Zhejiang AngLiKang Pharmaceutical CO.,LTD
Zhejiang AngLiKang Pharmaceutical CO.,LTD. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers chemical raw materials for pharmaceuticals comprising oral cephalosporin antibiotic raw materials, including cephalexin, cefadroxil, cefaclor, and cefadroxil; alpha-keto acid raw materials; inhaled anesthetic raw materials, such as isoflurane and sevoflurane; and anti-androgen intermediates, including finasteride and dutasteride. It also provides chemical agents consisting of anti-infective preparations, such as cefixime and cefadroxil capsules, cefaclor sustained-release tablets, cefaclor granules, and cefalexin capsules; cardiovascular preparations, including levamlodipine besylate and amlodipine besylate tablets, nifedipine sustained-release and sacubitril/valsartan sodium tablets, and measartan potassium and ticagrelor tablets; anesthetic and analgesic preparations, such as sevoflurane inhalation, liprocaine cream, and pregabalin capsules; nephropathy preparations, including compound a-keto acid tablets, levocarnitine oral solutions, and lanthanum carbonate chewable tablets; oryzanol and doxofylline tablets; and other products. In addition, the company offers specialty intermediates, such as plant-derived cholesterol and its derivatives, plant-derived vitamin D3, and plant-derived 25-hydroxyvitamin D3. Further, it provides lyophilized powder injections, steroidal biological products, and plant extracts; penicillin; and active pharmaceutical ingredients (APIs) for respiratory system, digestive system, and pain indications. Additionally, the company engages in biotechnology promotion activities. The company serves pharmaceutical companies, commercial and pharmaceutical distribution companies, chemical and nutritional companies, and feed companies. Zhejiang AngLiKang Pharmaceutical CO.,LTD. was founded in 2001 and is headquartered in Shengzhou, China.
Research context
Zhejiang AngLiKang Pharmaceutical CO.,LTD appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 7 months ago
Zhejiang AngLiKang Pharmaceutical CO.,LTD is currently in a long term downtrend where the price is trading 10.7% below its 200 day moving average.
From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.
Zhejiang AngLiKang Pharmaceutical CO.,LTD's total revenue sank by 2.7% to $310M since the same quarter in the previous year.
Its net income has increased by 55.4% to $39M since the same quarter in the previous year.
Finally, its free cash flow grew by 49.7% to $45M since the same quarter in the previous year.
Based on the above factors, Zhejiang AngLiKang Pharmaceutical CO.,LTD gets an overall score of 3/5.